← Back to patent-cliff list
Isoprocin glutarate
Tier C — Watch / tradeIsoprocin glutarate
Reunion Neuroscience Inc
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：5-HT2A
Indications (approved)：Anxiety disorder, 适应性障碍, 产后抑郁症, Treatment-resistant depression, Post-traumatic stress disorder, 情绪障碍
Regional status
US
Phase II
2024-06-14
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Isoprocin glutarate?
Approved indications include: Anxiety disorder, 适应性障碍, 产后抑郁症, Treatment-resistant depression, Post-traumatic stress disorder, 情绪障碍.
When does the Isoprocin glutarate patent expire?
No public expiry year is available for Isoprocin glutarate yet; this page updates once verified.
How do I get a quote for Isoprocin glutarate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-01